Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroleptic Treatment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00073164
What this trial is testing

Depakote ER Plus an Atypical Antipsychotic Vs. an Atypical Antipsychotic Alone in the Treatment of Schizophrenia

Who this might be right for
Schizophrenia
Abbott 400
Not applicableUnknownNCT01260116
What this trial is testing

Efficacy and Safety of Ziprasidone to Treat Depressive Symptoms in Patients With Schizophrenia

Who this might be right for
The Primary Evaluation is the Change From Baseline at End of Study for CDSS Total Scores.The Secondary Efficacy Evaluations Include: MADRS, PANSS Total Scores and Subscales and Responder Rate; CGI-S and CGI-I Scales.Safety Evaluations Include: Laboratory Test Abnormalities; BARS and SAS; Physical Examinations; Vital Signs; Electrocardiogram,Etc.+1 more
Wuhan University
Not applicableStudy completedNCT06787781
What this trial is testing

Metabolic and Clinical Effect of Alpha-lipoic Acid Administration in Schizophrenic Subjects

Who this might be right for
Metabolic EvaluationCardiac Complications
University of Messina 15
Post-approval studies (Phase 4)Study completedNCT00451399
What this trial is testing

Efficacy of Lifestyle Interventions and Metformin for the Treatment of Antipsychotic-Induced Weight Gain

Who this might be right for
Weight Gain
Central South University 128
Large-scale testing (Phase 3)Ended earlyNCT01908192
What this trial is testing

Adaptive Phase II Study to Evaluate the Safety & Efficacy of NaBen®

Who this might be right for
Schizophrenia
SyneuRx International (Taiwan) Corp 60
Large-scale testing (Phase 3)UnknownNCT04528095
What this trial is testing

SMART Design to Compare Antipsychotic Treatments in Treatment-Resistant Schizophrenia

Who this might be right for
Treatment-resistant Schizophrenia
Shanghai Mental Health Center 162
Post-approval studies (Phase 4)Study completedNCT00297739
What this trial is testing

Risperidone Augmentation for Treatment-Resistant Aggression in ADHD

Who this might be right for
Aggression
Armenteros, Jorge L., M.D., P.A. 25
Not applicableStudy completedNCT02220504
What this trial is testing

3-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals

Who this might be right for
SchizophreniaSchizophrenia RelapseSchizophrenia Spectrum and Other Psychotic Disorders
Fundación Marques de Valdecilla 68
Large-scale testing (Phase 3)UnknownNCT04093518
What this trial is testing

Estradiol as add-on to Antipsychotics

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorders
Tangent Data 100
Not applicableStudy completedNCT01145313
What this trial is testing

Impact of Atypical Antipsychotic Therapy on Health Outcomes and Costs Among Patients With Major Depressive Disorder

Who this might be right for
Depressive Disorder, Major
Otsuka Pharmaceutical Development & Commercialization, Inc. 501
Not applicableUnknownNCT04335916
What this trial is testing

Survey on Pre-ECT Evaluation and ECT Application

Who this might be right for
DepressionCatatoniaSchizophrenia+3 more
Klinički Bolnički Centar Zagreb 30
Large-scale testing (Phase 3)Study completedNCT02469155
What this trial is testing

A Trial to Assess the Antipsychotic Efficacy of ITI-007 Over 6 Weeks of Treatment

Who this might be right for
Schizophrenia
Intra-Cellular Therapies, Inc. 696
Not applicableStudy completedNCT03019887
What this trial is testing

Correlation Between Cognitive Function and Relapse of Schizophrenia Regarding Dose Reduction

Who this might be right for
Schizophrenia Relapse
Juntendo University 139
Large-scale testing (Phase 3)Study completedNCT01858948
What this trial is testing

SGA-induced Metabolic Syndrome in Bipolar Youth

Who this might be right for
Bipolar Youth Treated With Second-generation Antipsychotics
University of Cincinnati 19
Large-scale testing (Phase 3)Study completedNCT02194933
What this trial is testing

Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Schizophrenia With Impulsivity

Who this might be right for
Schizophrenia With Impulsivity
Otsuka Pharmaceutical Development & Commercialization, Inc. 38
Large-scale testing (Phase 3)Ended earlyNCT01509053
What this trial is testing

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 30
Not applicableLooking for participantsNCT07696000
What this trial is testing

The Effect of Structured Medical Nutrition Therapy on Systemic Inflammation Index in Patients With Schizophrenia Receiving Antipsychotic Therapy

Who this might be right for
Schizophrenia / Schizoaffective Disorder
DINA KEUMALA SARI 100
Post-approval studies (Phase 4)Study completedNCT00649064
What this trial is testing

The Effects of Ziprasidone for the Treatment of Schizophrenia or Schizoaffective Disorder in Patients Who Were Switched From Other Antipsychotic Drugs

Who this might be right for
Schizoaffective DisorderSchizophrenia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 46
Post-approval studies (Phase 4)Study completedNCT01578486
What this trial is testing

Salsalate as an Adjunctive Treatment for Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
University of Massachusetts, Worcester 17
Post-approval studies (Phase 4)Looking for participantsNCT04478838
What this trial is testing

"Extended" (Alternate Day) Antipsychotic Dosing

Who this might be right for
Schizophrenia and Related DisordersDrug Administration ScheduleDrug Therapy+1 more
Centre for Addiction and Mental Health 120
Next Page
120